ClinVar Miner

Submissions for variant NM_000492.4(CFTR):c.3177A>G (p.Leu1059=)

gnomAD frequency: 0.00003  dbSNP: rs1800113
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 8
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories RCV004704831 SCV001157173 likely benign not provided 2024-09-25 criteria provided, single submitter clinical testing
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV001000389 SCV001362677 likely benign not specified 2019-08-30 criteria provided, single submitter clinical testing
Johns Hopkins Genomics, Johns Hopkins University RCV001250547 SCV001425367 likely benign Cystic fibrosis 2020-05-08 criteria provided, single submitter clinical testing
Labcorp Genetics (formerly Invitae), Labcorp RCV001250547 SCV001683299 likely benign Cystic fibrosis 2024-09-27 criteria provided, single submitter clinical testing
Ambry Genetics RCV001250547 SCV002610188 likely benign Cystic fibrosis 2016-10-13 criteria provided, single submitter clinical testing This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
Breakthrough Genomics, Breakthrough Genomics RCV004704831 SCV005221520 likely benign not provided criteria provided, single submitter not provided
Natera, Inc. RCV001250547 SCV001461256 likely benign Cystic fibrosis 2020-09-16 no assertion criteria provided clinical testing
PreventionGenetics, part of Exact Sciences RCV004537228 SCV004726088 likely benign CFTR-related disorder 2023-12-11 no assertion criteria provided clinical testing This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.